METLIFE, INC.

MET

CIK 0001099219 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$23.81B
↑+27.6% +$5.15Bvs FY2024 (Q4)
Operating Income
$1.68B
↑+12.6% +$188Mvs FY2024 (Q4)
Net Income
$809M
↓-36.3% -$462Mvs FY2024 (Q4)
Gross Profit
$7.04B
↑+15.5% +$944Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
46/100
  • Profitability
    55ROIC 16.0% (10% = solid, 20%+ = moat)
  • Liquidity
    0Insufficient data
  • Leverage
    80D/E 0.41 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.11x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +27.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    43Op Margin 7.1% · trend -0.4pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project MET's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

9%

Trailing 3-yr CAGR was 9.4%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$454.96
Total enterprise IV
$306.32B
Diluted shares
0.67B
Terminal PV
$223.16B (73% of total)
Year-5 FCF
$26.30B
YearProjected FCFDiscounted PV
+1$18.63B$16.94B
+2$20.31B$16.78B
+3$22.13B$16.63B
+4$24.13B$16.48B
+5$26.30B$16.33B
Terminal$359.41B$223.16B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Dividends paid (TTM)
$1.51B
cash returned to holders
Stock buybacks (TTM)
$2.88B
share count reduction

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$745.17B
everything owned
Total liabilities
$716.25B
everything owed
Stockholders' equity
$28.40B
shareholder claim
Net debt
$-3.15B
Net cash position ($3.15B)

Recent performance · 72 quarters

Revenue↑+27.6% +$5.15B
$23.81B
Net Income↓-36.3% -$462M
$809M
Free Cash Flow↑+53.5% +$2.46B
$7.08B
Operating Margin↓-0.9pts
7.1%

Drill down